UBP-302
UBP-302
UBP-302 (pronounced: yoo-bee-pee-three-zero-two) is a synthetic compound known for its potential therapeutic applications in the field of neuroscience and pharmacology.
Etymology
The term "UBP-302" is an acronym derived from the name of the research group that first synthesized it, the University of Bristol Pharmacology department (UBP), and the number 302 represents the specific compound number in their research series.
Definition
UBP-302 is a potent and selective antagonist for the glutamate receptor, specifically the group I metabotropic glutamate receptors (mGluR1 and mGluR5). It is often used in research to study the role of these receptors in various neurological and psychiatric disorders.
Related Terms
- Glutamate receptor: A type of protein found in nerve cells that receives signals in the form of the neurotransmitter glutamate.
- Neurotransmitter: Chemicals that transmit signals from a neuron to a target cell across a synapse.
- Antagonist: A substance that interferes with or inhibits the physiological action of another.
- Metabotropic glutamate receptors (mGluRs): A type of glutamate receptor that is active through an indirect metabotropic process.
- Neuroscience: The scientific study of the nervous system.
- Pharmacology: The branch of medicine concerned with the uses, effects, and modes of action of drugs.
External links
- Medical encyclopedia article on UBP-302
- Wikipedia's article - UBP-302
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski